ArticleOncotarget2018
PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.
Caroline Spasojevic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleOncotarget2018
Caroline Spasojevic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.